
Medicare insider trading case casts a spotlight on political intelligence
Prosecutors allege that consultant David Blaszczak learned that Medicare was planning to cut the amount it reimburses doctors who used certain types of therapy on cancer patients and relayed the information to contacts at Deerfield Management.